Latest Form 4 insider transactions

NYSE
Robert Ledford, a Director of Orion Group Holdings Inc, purchased 20,000 shares of common stock on July 31, 2026 for $9.62 per share.
NASDAQ
Chad Jeffrey Hartley, Group President of Astec Industries Inc, received 12,979 shares of common stock on August 1, 2026.
NYSE
Jeffery S. Mcelfresh, Chief Operating Officer of At&T Inc., received 2,690 shares of common stock on July 31, 2026.
NYSE
Kevin R Thornal, Grp Pres-Global Business of Zimmer Biomet Holdings, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
Andrew R Harrison, EVP AND CCO of Alaska Air Group, Inc., sold 5,300 shares of common stock on August 3, 2026 for $49.67 per share.
NYSE
BlackRock Portfolio Management LLC reported changes in beneficial ownership of Yellowstone Midco Holdings II, LLC common stock on July 31, 2026.
NASDAQ
Louis J Torchio, President & CEO and a Director of Northwest Bancshares, Inc., received 125,298 shares of common stock on July 31, 2026.
NYSE
Alejandro T Vallejo, EVP, Chief People Officer of PG&E Corp, reported multiple transactions in common stock on August 1, 2026.
NYSE
Raymond H Lewis Jr, SVP, Chief Human Resources of Hayward Holdings, Inc., reported a transaction in 1,236 shares of common stock on August 3, 2026.
NYSE
David L Finkelstein, CEO and Co-CIO and a Director of Annaly Capital Management Inc, sold 50,000 shares of common stock on August 3, 2026 for $22.89 per share.
NYSE
William K Gerber, a Director of Wolverine World Wide Inc /De/, received 181 shares of common stock on August 3, 2026.
NASDAQ
Frederick J. Fritz, a Director of Imunon, Inc., received 6,934 shares of common stock on July 31, 2026.
OQB
Albert L Lord, a Director of AppTech Payments Corp., purchased 40,000 shares of common stock on July 31, 2026.
NYSE
Matthew K Rose, a Director of At&T Inc., received 4,238 shares of common stock on July 31, 2026.
NASDAQ
Jason E Estes, Exec. Vice President; CCO of Bank7 Corp., sold 2,477 shares of common stock on August 3, 2026.
NYSE
John H Stone, President and CEO and a Director of Allegion plc, reported a transaction in 11,292 shares of common stock on August 1, 2026.
NASDAQ
Susan Eylward, General Counsel and Corp Sec of Imunon, Inc., sold 2,541 shares of common stock on July 31, 2026 for $1.57 per share.
AMEX
Shahrez Nadeem, COO and Secretary of Legato Merger Corp. IV, purchased 2,585 shares of common stock on August 3, 2026 for $0.00 per share.
NYSE
Christopher Hufnagel, President and CEO of Wolverine World Wide Inc /De/, reported multiple transactions in common stock on July 31, 2026.
NYSE
Da-Wai Hu, General Counsel & Secretary of Chewy, Inc., reported a transaction in 909 shares of common stock on July 31, 2026.
NYSE
Joseph A. Schottenstein, a Director of Designer Brands Inc., received 3,725 shares of common stock on July 31, 2026.
NYSE
Laura Davis, EVP;Pres DSW Designer ShoeWhse of Designer Brands Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
Michael B Mccallister, a Director of At&T Inc., received 1,974 shares of common stock on July 31, 2026.
AMEX
Adam H Jaffe, CFO and a Director of Legato Merger Corp. IV, purchased 22,749 shares of common stock on August 3, 2026 for $0.00 per share.
NASDAQ
Steve Schuller, SVP, Human Resources of Frontier Group Holdings, Inc., sold 10,000 shares of common stock on August 3, 2026 for $7.55 per share.
NYSE
Marissa A Mayer, a Director of At&T Inc., received 543 shares of common stock on July 31, 2026.
NASDAQ
Alexandre Clerc, SVP, Customers of Frontier Group Holdings, Inc., sold 10,210 shares of common stock on July 31, 2026.
AMEX
Eric Rosenfeld, Chief SPAC Officer of Legato Merger Corp. IV, purchased 47,566 shares of common stock on August 3, 2026 for $0.00 per share.
NASDAQ
Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc., received 3,649 shares of common stock on July 31, 2026.
NASDAQ
Thomas G Wiggans, a Director of Jasper Therapeutics, Inc., received 7,500 shares of common stock on July 31, 2026.